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1 
Appendicular skeletal muscle in hospitalized hip-fracture patients: Development and 
cross-validation of anthropometric prediction equations against dual-energy X-ray 
absorptiometry 
Running Title: Development and validation of appendicular skeletal muscle equations for 
hip fracture patients 
 2 
Abstract 
Background: Accurate and practical assessment methods for assessing appendicular skeletal 
muscle (ASM) is of clinical importance for diagnosis of geriatric syndromes associated with 
skeletal muscle wasting.  
Objectives: The purpose of this study was to develop and cross-validate novel 
anthropometric prediction equations for the estimate of ASM in older adults post-surgical 
fixation for hip fracture, using dual energy X-ray absorptiometry (DEXA) as the criterion 
measure.  
Subjects: Community-dwelling older adults (aged ≥65 years) recently hospitalised for hip 
fracture. 
Setting: Participants were recruited from hospital in the acute phase of recovery.   
Design: Validation measurement study. 
Measurements: A total of 79 hip fracture patients were involved in the development of the 
regression models (MD group). A further 64 hip fracture patients also recruited in the early 
phase of recovery were used in the cross-validation of the regression models (CV group). 
Multiple linear regression analyses were undertaken in the MD group to identify the best 
performing prediction models. The linear coefficient of determination (R2) in addition to the 
standard error of the estimate (SEE) were calculated to determine the best performing model. 
Agreement between estimated ASM and ASMDEXA in the CV group was assessed using 
paired t tests with the 95% limits of agreement (LOA) assessed using Bland-Altman analyses. 
Results: The mean age of all participants was 82.1 ± 7.3 years. The best two prediction 
models are presented as follows: ASMPRED-EQUATION_1: 22.28 - (0.069 * age) + (0.407 * 
weight) – (0.807 * BMI) – (0.222 * MAC) (adjusted R2: 0.76; SEE: 1.80kg); ASMPRED-
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EQUATION_2: 16.77 – (0.036 * age) + (0.385 * weight) – (0.873 * BMI) (adjusted R2: 0.73; 
SEE: 1.90kg). Mean bias from the CV group between ASMDEXA and the predictive equations 
are as follows: ASMDEXA – ASMPRED-EQUATION_1: 0.29 ± 2.6kg (LOA: -4.80, 5.40kg); 
ASMDEXA – ASMPRED-EQUATION_2: 0.13 ± 2.5kg (LOA: -4.77, 5.0kg). No significant 
difference was observed between measured ASMDEXA and estimated ASM (ASMDEXA: 16.4 ± 
3.9kg; ASMPRED-EQUATION_1: 16.7 ± 3.2kg (P = 0.379); ASMPRED-EQUATION_2: 16.6 ± 3.2kg (P 
= 0.670)) 
Conclusions: We have developed and cross-validated novel anthropometric prediction 
equations against DEXA for the estimate of ASM designed for application in older 
orthopaedic patients. Our equation may be of use as an alternative to DEXA in the diagnosis 
of skeletal muscle wasting syndromes. Further validation studies are required to determine 
the clinical utility of our equation across other settings, including hip fracture patients 
admitted from residential care, and also with longer-term follow-up.  
 
Key words: older adults; hip fracture; body composition; appendicular skeletal muscle; 
prediction equations; sarcopenia; geriatric cachexia   
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Introduction 1 
Body composition assessment, particularly skeletal muscle mass (SMM), is a key component 2 
of assessing the health and functional status of older adults[1]. Assessing SMM, specifically 3 
appendicular skeletal muscle (ASM), is a key diagnostic feature for the assessment of 4 
geriatric syndromes associated with skeletal muscle wasting, such as sarcopenia[2] and 5 
geriatric cachexia[3]. Older adults with recent hip fractures are an important clinical group at 6 
increased risk of significant reductions in SMM and adverse health outcomes including 7 
frailty, progressive disability, institutionalization and subsequent mortality post-surgery [4, 8 
5].  9 
 10 
Dual energy X-ray absorptiometry (DEXA) is commonly referred to as a reference technique 11 
for assessing body composition [6]. However its high cost, routine availability within the 12 
clinical setting and the potential challenges for measurement of frail older adults recovering 13 
from surgery highlights the need for practical alternatives [7]. 14 
 15 
Upper-arm anthropometry offers a quick, portable and inexpensive method of assessing body 16 
composition. Previous prediction models using a set of appendicular circumferences and 17 
skinfolds have been developed and cross-validated [8-10]. However such validation studies 18 
are yet to be undertaken in nutritionally vulnerable hospitalized older adults with hip fracture. 19 
Visvanathan et al [11] recently developed and validated an anthropometric predication 20 
equation for application in older adults; however, the sample used to establish and validate 21 
this equation were not representative of a hip fracture sample, with few participants aged 22 
≥80years, few having BMIs ≤22kgm-2 and were otherwise healthy community dwelling 23 
adults (mean age: 50.6 ± 15.7 years); moreover, it has been suggested that the application of 24 
general predictive equations in populations different to which they are derived should be 25 
 5 
avoided[12]. Therefore, the objective of this study was to develop and cross-validate novel 26 
anthropometric prediction models for the assessment of ASM in a sample of older adults 27 
post-surgical fixation for hip fracture using DEXA as the criterion measure.   28 
 29 
 30 
 31 
 32 
 33 
 34 
 35 
 36 
 37 
 38 
 39 
 40 
 41 
 42 
 43 
 44 
 45 
 46 
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 48 
 49 
 50 
 51 
 52 
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Methods 53 
Patients and Recruitment 54 
These were cross-sectional analyses performed in older adults post-surgical fixation for hip 55 
fracture. Body composition data were collected at baseline in a sample of hip fracture patients 56 
recruited from two randomized controlled trials (RCT) conducted by our group: 1) 57 
INTERACTIVE trial (ACTRN 12607000017426) [13]; 2) ATLANTIC trial (ACTRN 58 
12609000241235) [14].  59 
 60 
Participants were eligible for each respective study if they were admitted to hospital with a 61 
diagnosis of hip fracture confirmed by radiology report, had a Mini Mental State Examination 62 
(MMSE) score of 18/30, had a body mass index (BMI) between 18.5kgm-2 and 35kgm-2 63 
and were community-dwelling. This study was conducted according to the guidelines 64 
described in the Declaration of Helsinki with all procedures involving human subjects 65 
approved by the Human Research Ethics Committee at each recruitment site.  66 
 67 
 68 
Body composition measurements and procedures 69 
A detailed description of all outcome measures from both investigations are reported 70 
elsewhere [13, 14]. For the purpose of the present validation study, participants recruited 71 
from the INTERACTIVE trial were used as the model development (MD) group. Predictor 72 
variables including weight, BMI, mid-arm circumference (MAC), triceps skinfolds (TSF), 73 
age and gender were used in the development of the prediction model. Using the same 74 
predictor variables, participants recruited from the ATLANTIC trial acted as the cross-75 
validation (CV) group.      76 
 77 
 7 
Weight and height 78 
Body weight was recorded to the nearest 0.1kg using calibrated digital scales with 79 
participants wearing light clothing and without footwear. Participants who were unable to 80 
mobilize were weighed using a calibrated weigh chair. Height was estimated from knee 81 
height using validated age and gender specific equations[15]. BMI was calculated as weight 82 
(kg) divided by the square of estimated height (m). 83 
 84 
Dual-energy X-ray absorptiometry 85 
Whole body and regional body composition were estimated using Lunar Prodigy DEXA and 86 
automated reporting GE EnCORE bone densitometry software (version 10.51.006). The 87 
system software also provides estimates of ASM, defined as the sum of lean soft tissue mass 88 
in both arms and legs [6].  89 
 90 
Upper arm anthropometry  91 
MAC was measured at the mid-point between the superior and lateral border of the acromion 92 
process and the proximal and lateral border of the radial head to the nearest 0.1cm using a 93 
flexible steel measuring tape. TSF thickness was measured at the marked posterior mid-94 
acromiale-radiale to the nearest 0.2mm using a calibrated Harpenden skinfold calliper. All 95 
anthropometric measures were performed by trained staff. Unless affected by injury, all 96 
anthropometric measures were taken on the right-hand side of the body. 97 
 98 
 99 
 100 
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Statistical Analyses 101 
 102 
Analyses were performed using SPSS for Windows 21.0. Significance was set at P <0.05. 103 
Differences between the MD and CV cohorts were examined by independent samples t-test. 104 
Using ASMDEXA as the criterion measure, multiple linear regression analysis was undertaken 105 
in the MD group to identify the best performing predictive models. In the development of the 106 
prediction model, we selected predictor variables based on the results of the correlation 107 
analyses and their relationship with ASMDEXA. Variables displaying no significant 108 
relationship in the regression model were removed from the final prediction model.  The 109 
linear coefficient of determination (R2) in addition to the standard error of the estimate (SEE) 110 
were calculated. The equations developed in the MD group were used to calculate predicted 111 
ASM in the CV group. Agreement between estimated ASM and ASMDEXA was assessed 112 
using paired t tests to identify fixed bias with the limits of agreement (LOA) between the two 113 
measures assessed using Bland and Altman analyses [16, 17].     114 
 115 
 116 
 117 
 118 
 119 
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 125 
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Results 127 
79 participants in the MD group (Male, n = 23; Female, n = 56) and 64 participants (Male, n 128 
= 14; Female, n = 50) in the CV group contributed data. Mean (SD) weight, BMI, MAC, TSF 129 
thickness and ASM for both groups are presented in Table 1.  130 
 131 
In relation to all other predictor variables in the model, TSF thickness and gender resulted in 132 
a weak, non-significant contribution to the regression model (TSF thickness: β = 0.093; P = 133 
0.260; Gender: β = 0.142; P = 0.095).  134 
 135 
The best two performing prediction models are presented as follows: 136 
ASMPRED-EQUATION_1: 22.28 - (0.069 * age) + (0.407 * weight) – (0.807 * BMI) – (0.222 * 137 
MAC); Adjusted R2: 0.76; SEE: 1.80kg  138 
ASMPRED-EQUATION_2: 16.77 – (0.036 * age) + (0.385 * weight) – (0.873 * BMI); Adjusted 139 
R2: 0.73; SEE: 1.90kg 140 
[Age in years; weight in kg; BMI: weight (kg) divided by the square of height (m) (kgm-2); 141 
MAC in cm]. 142 
 143 
 144 
When assessing agreement in the CV group, no significant difference was observed between 145 
measured ASMDEXA and estimated ASM (ASMDEXA: 16.4 ± 3.9kg; ASMPRED-EQUATION_1: 16.7 146 
± 3.2kg (P = 0.379); ASMPRED-EQUATION_2: 16.6 ± 3.2kg (P = 0.670)). Mean bias from the CV 147 
group between ASMDEXA and the predictive equations are as follows: ASMDEXA – ASMPRED-148 
EQUATION_1: 0.29 ± 2.6kg (LOA: -4.80, 5.40kg); ASMDEXA – ASMPRED-EQUATION_2: 0.13 ± 149 
2.5kg (LOA: -4.77, 5.0kg). Bland-Altman plots of the comparisons are highlighted in Figure 150 
1.   151 
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Discussion 152 
To the best of our knowledge, this is the first study to develop and validate anthropometric  153 
predictive equations for the estimate of ASM in hip fracture patients. Our equations may be 154 
of use for clinical application and useful as an alternative to DEXA for inclusion in the 155 
assessment of geriatric syndromes. 156 
 157 
 At present, there are several published predictive equations that use bioelectrical impedance 158 
analysis as a reference method developed for application in older adults for the assessment of 159 
SMM, ASM and/or FFM [18-22]; however, the development of body composition predictive 160 
equations amongst hip fracture patients is scant. We have previously applied one these 161 
equations [22] to our MD sample of hip fracture patients and reported clinically unacceptable 162 
discordance from SMMDEXA, thus supporting the argument for population specific algorithms 163 
that demonstrate clinically acceptable agreement with DEXA [23, 24].  164 
 165 
Results from the present study  are consistent with those presented by Visvanathan et al  (Adj 166 
R2 = 0.87; SEE = 1.95)[11]. Unlike our prediction models, the best performed model 167 
established by Visvanathan et al [11] used BMI, weight, age and gender. Although the model 168 
proposed by Visvanathan et al [11] explained a greater variance of ASMDEXA, this is likely 169 
attributable to the heterogeneity in the body composition status of our hip fracture sample, 170 
differences in age and the acute phase of injury. Unexpectedly, in the present study, gender 171 
demonstrated a weak and non-significant contribution to the regression model and was 172 
subsequently removed from both final prediction models; it is possible that this could be 173 
attributable to a gender discrepancy among both hip fracture cohorts with males 174 
underrepresented relative to females. 175 
 176 
11 
A major strength of this study was the fact that we developed and cross-validated our 177 
prediction models in the hip fracture population. Moreover, our prediction equation also 178 
included simple upper arm limb circumference as a predictor variable, in addition to more 179 
routine anthropometric measures such as weight and BMI. Although TSF thickness was 180 
originally a selected independent variable of interest, it demonstrated a weak and non-181 
significant contribution to the regression model and accordingly was not included in the 182 
predictive equations. The significant difference observed in TSF thickness between the two 183 
hip fracture cohorts was likely associated with the sample recruited, with investigators from 184 
the CV group specifically recruiting cachectic hip fracture patients [14]. Less likely, but 185 
possible, is that protocol violations in measurement of TSF may have been responsible for the 186 
significant difference observed in TSF thickness between the two hip fracture cohorts and the 187 
lack of association between TSF thickness and ASMDEXA. Measurement of TSF can be 188 
challenging and despite best efforts to train and monitor staff performance, we cannot be 189 
certain that measures were routinely undertaken according to protocol. 190 
191 
A potential limitation of the present study was the exclusion of additional predictor variables 192 
which may have strengthened our model, including additional appendicular limb 193 
circumferences and isometric handgrip strength. Importantly, the potential for selection bias 194 
at study entry (i.e. BMI between 18.5 and 35 kgm-2, community dwelling, medically stable 195 
and ambulatory pre-fracture) resulted in potential sarcopenic and cachectic patients being 196 
excluded from the study, which may indeed limit the generalisability of these equations; the 197 
latter considerations are pertinent because validation studies for our prediction models are 198 
required, particularly in a larger sample of hip fracture patients which specifically include 199 
more vulnerable patients such as those living in residential aged care facilities. 200 
201 
12 
In conclusion, we have developed and cross-validated novel anthropometric prediction 202 
equations for the estimate of ASM designed for application in older adults post-surgery for 203 
hip fracture. Our prediction equations have potential to contribute to the diagnosis of skeletal 204 
muscle wasting syndromes in clinical care settings when DEXA scans are unavailable or 205 
unsuitable.  206 
207 
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Table 1. Post-surgical anthropometric characteristics in two hip fracture cohorts 234 
(all such variables reported as mean ± SD) 235 
 236 
MD, model development group; CV, cross-validation group; BMI, body mass index; MAC, 237 
mid-arm circumference; TSF, triceps skinfold thickness; ASM, appendicular skeletal muscle; 238 
DEXA, dual energy X-ray absorptiometry. 239 
a INTERACTIVE participants used in the development of the prediction models; n = 79 hip 240 
fracture patients with complete DEXA and anthropometric data. 241 
b ATLANTIC participants used in the cross-validation of the prediction models; n = 64 hip 242 
fracture patients with complete DEXA and anthropometric data. 243 
c Significant differences in predictor variables between the MD and CV groups assessed by 244 
independent samples t-test (P <0.05). 245 
All data were collected at baseline within 14-days post-surgery for INTERACTIVE 246 
participants or within 7-days post-surgery for ATLANTIC participants.  247 
 248 
 
 
 
All 
 
MD group a 
(INTERACTIVE) 
n = 79 
 
  
CV group b  
(ATLANTIC) 
n = 64 
 
 Mean SD Mean SD Mean SD 
Age (years) 
Weight (kg) 
82.1 
64.3 
7.3 
13.8 
82.7 
65.4 
5.9 
14.0 
81.1 
62.6 
8.9 
13.3 
BMI (kgm-2) 
MAC (cm) 
TSF thickness (mm) 
ASMDEXA (kg) 
24.7 
26.0 
14.6 
16.8 
4.2 
4.0 
5.9 
3.8 
24.9 
26.2 
15.2c 
17.2 
4.0 
3.8 
5.6 
3.8 
24.3 
25.6 
13.5c 
16.4 
4.5 
4.2 
6.2 
3.9 
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Figure 1. Bland-Altman Plots: mean bias and 95% limits of agreement (LOA) for the 249 
assessment of predicted ASM and measured ASMDEXA, the reference technique. In this 250 
technique, the difference between measured ASMDEXA and predicted ASM (i.e. mean bias) 251 
was plotted along the vertical axis against the mean of the two measures on the horizontal 252 
axis where the aim was to describe the variability in agreement between the two measures. 253 
Assuming a normal distribution of differences, theoretically, 95% of the differences are 254 
expected to be within ± 2SD; a) ASMDEXA vs ASMPRED-EQUATION_1; b) ASMDEXA vs ASMPRED-255 
EQUATION_2.  The solid bold line represents the mean difference between measured ASMDEXA 256 
and predicted ASM. The two dashed lines illustrate the 95% LOA (± 2SD) between the two 257 
measures.  258 
 259 
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